[1]李长天,陈雁飞.葛根素对糖尿病大鼠肾脏糖基化终产物和转化生长因子-β1表达的影响[J].中国中医药信息杂志,2006,13(3):36-38.
 LI Chang-Tian,CHEN Yan-Fei.Effects of Puerarin on Renal Advanced Glycosylation End Products and Expression of TGF-β1 in Diabetic Rats[J].zhongguo zhongyiyao xinxi zazhi,2006,13(3):36-38.
点击复制

葛根素对糖尿病大鼠肾脏糖基化终产物和转化生长因子-β1表达的影响

参考文献/References:

[1] Sheldon Chen, Soon Won Hong, M Carmen Iglesias-da IaCruz, et al. The key role of the transforming growth factor-βsystem in the pathogenesis of diabetic nephropathy[J].Renal Failure,2001, 23:471-479.

[2] Yang CW, Vlassara H, Peten Ep, et al. Advanced glycosylation end products up-regulate gene expression found in diabetic glomerular disease[J].Proc Natl Acad Sci,1994,91:9436-9450.

[3] 段有金,王韵颖,三轮一智,等.五种中药对蛋白质非酶糖基化的抑制作用[J].中国糖尿病杂志,1986,6:229-231.

[4] 金 纯,钟福高,杨建新,等.葛根素降低Ⅱ型糖尿病患者微量白蛋白的临床观察[J].中华老年医学杂志,2002,21:57-60.

[5] Shank land, Scholey JW, LYH, et al. Expression of transforming growth factor-β during diabetic renal hypertrophy[J].Kidney Int,1994,40:430-432.

[6] Hammes HP, Sabine M, Konrad F, et al. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy [J].Proc Natl Acad Sci USA,1991,88:11555-11558.

[7] 姚 建,陈名道.糖尿病肾病及其早期防治[J].中华内分泌代谢杂志, 2002,18:330-332.

[8] Gilbert RE, Cox A, Wu LL, et al. Expression of transforming growth factor-β1 and type IV collagen in the renal tubulointerstitium in experimental diabetes[J].Diabetes,1998,47:414-425.

[9] Wolf G, Schroder R, Ziyadeh FN, et al. High glucose stimulates expression of p27kip1 in cultured mouse mansangial cells:relationship to hypertrophy[J].Am J Physiol,1997,273:348-357.

[10] Wolf G, Ziya FN. Molecular mechanisms of diabetic renal hypertrophy[J].Kidney Int,1999,56:393-397.

相似文献/References:

[1]艾碧琛,肖漫江,喻嵘,等.降糖益肾方对MKR鼠2型糖尿病肾病早期的保护作用[J].中国中医药信息杂志,2010,17(3):29.
 AI Bi-chen,XIAO Man-jiang,YU Rong,et al.Protective Effect of Jiangtangyishen Decoction on Early-stage Diabetic Nephropathy of MKR Mice[J].zhongguo zhongyiyao xinxi zazhi,2010,17(3):29.
[2]周琴妹,丁琪.痤疮灵颗粒的定性定量标准研究[J].中国中医药信息杂志,2010,17(10):43.[doi:10.3969/j.issn.1005-5304.2010.10.018]
 ZHOU Qin-mei,DING Qi.Study on Qualitative and Quantitative Standard of Cuochuangling Keli[J].zhongguo zhongyiyao xinxi zazhi,2010,17(3):43.[doi:10.3969/j.issn.1005-5304.2010.10.018]
[3]孔建平,孔小云.心可舒和葛根素治疗不稳定型心绞痛临床观察[J].中国中医药信息杂志,2007,14(1):74.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(3):74.
[4]黄彦彬,张佩青,张玉梅,等.张琪辨治泌尿系疾病经验举隅[J].中国中医药信息杂志,2009,16(7):84.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(3):84.
[5]周素娴,赵晋晋,雷闽湘.黄芪对高糖高脂环境下内皮细胞与系膜细胞相互作用的影响[J].中国中医药信息杂志,2009,16(8):26.
 ZHOU Su-xian,ZHAO Jin-jin,LEI Min-xiang.Effect of Astragalus Membranaceus on the Interaction of Mesangial Cells and Endothelial Cells[J].zhongguo zhongyiyao xinxi zazhi,2009,16(3):26.
[6]姚逸,伍晓丽,杨清林.国内近年糖尿病肾病研究的文献计量学分析[J].中国中医药信息杂志,2009,16(12):92.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(3):92.
[7]陈国昌,张灼,彭海东,等.天荔汤对糖尿病大鼠肾脏氧化应激的影响[J].中国中医药信息杂志,2007,14(3):26.
 CHEN Guo-Chang,ZHANG Zhuo,PENG Hai-dong,et al.Effects of Tianli Decoction on Oxidative Stress in the Kidney of Diabetic Rat[J].zhongguo zhongyiyao xinxi zazhi,2007,14(3):26.
[8]张裕强,朱华旭,郭立玮.葛黄活血胶囊质量控制标准研究[J].中国中医药信息杂志,2008,15(3):53.
 ZHANG Yu-qiang,ZHU Hua-xu,GUO Li-wei.Study on the Quality Control Standard of Gehuang Huoxue Capsules[J].zhongguo zhongyiyao xinxi zazhi,2008,15(3):53.
[9]解克芳,王继峰,牛建昭.葛根素对人胚肺成纤维细胞增殖及细胞外基质合成的影响[J].中国中医药信息杂志,2008,15(5):39.
 XIE Ke-fang,WANG Ji-feng,NIU Jian-zhao.Effects of Puerarin on Proliferation of Human Embro Fibroblast Proliferation and Extracelluar Matrix in Vitro[J].zhongguo zhongyiyao xinxi zazhi,2008,15(3):39.
[10]尹德海,梁晓春.从肾小球系膜细胞表型转化谈中医药防治糖尿病肾病机制研究思路[J].中国中医药信息杂志,2008,15(6):90.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(3):90.

备注/Memo

基金项目:甘肃中医药管理局资助项目(2003-GZK-48)

更新日期/Last Update: